A phase 1/2 study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia
一项在亚洲开展的针对新诊断急性髓系白血病患者的吉瑞替尼联合化疗的1/2期临床研究
期刊:International Journal of Hematology
影响因子:1.8
doi:10.1007/s12185-024-03840-x
Sawa, Masashi; Miyamoto, Toshihiro; Kim, Hee-Je; Hiramatsu, Yasushi; Cheong, June-Won; Ikezoe, Takayuki; Naoe, Tomoki; Akashi, Koichi; Morita, Satoshi; Kosako, Masanori; Ikegaya, Moyu; Terada, Wataru; Kadokura, Takeshi; Hill, Jason; Miyawaki, Shuichi; Gill, Stanley C; Heinloth, Alexandra; Hasabou, Nahla